Retrospective Analysis of 397 Dermatoses Inpatients Associated with Blood Eosinophilia

References

• Wechsler ME, Munitz A, Ackerman SJ, et al. Eosinophils in health and disease: a state-of-the-art review. Mayo Clin Proc. 2021;96(10):2694–2707. doi:10.1016/j.mayocp.2021.04.025
   PubMed Web of Science ®Google Scholar
• Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2006;24:147–174. doi:10.1146/annurev.immunol.24.021605.090720
   PubMed Web of Science ®Google Scholar
• Long H, Zhang G, Wang L, Lu Q. Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol. 2016;50(2):189–213. doi:10.1007/s12016-015-8485-8
   PubMed Web of Science ®Google Scholar
• Leiferman KM, Peters MS. Eosinophil-related disease and the skin. J Allergy Clin Immunol Pract. 2018;6(5):1462–1482.e1466. doi:10.1016/j.jaip.2018.06.002
   PubMed Web of Science ®Google Scholar
• Radonjic-Hoesli S, Brüggen MC, Feldmeyer L, Simon HU, Simon D. Eosinophils in skin diseases. Semin Immunopathol. 2021;43(3):393–409. doi:10.1007/s00281-021-00868-7
   PubMed Web of Science ®Google Scholar
• Mansur AT, Göktay F, Yaşar SP. Peripheral blood eosinophilia in association with generalized pustular and erythrodermic psoriasis. J Eur Acad Dermatol Venereol. 2008;22(4):451–455. doi:10.1111/j.1468-3083.2007.02489.x
   PubMed Web of Science ®Google Scholar
• Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(1):129–148. doi:10.1002/ajh.26352
   PubMed Web of Science ®Google Scholar
• Leru PM. Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm. Clin Transl Allergy. 2019;9(1):36. doi:10.1186/s13601-019-0277-4
   PubMedGoogle Scholar
• Hougaard M, Thomsen GN, Kristensen TK, et al. A retrospective cohort study of patients with eosinophilia referred to a tertiary centre. Dan Med J. 2022;69(4): A07210558
   PubMed Web of Science ®Google Scholar
• Acharya KR, Ackerman SJ. Eosinophil granule proteins: form and function. J Biol Chem. 2014;289(25):17406–17415. doi:10.1074/jbc.R113.546218
   PubMed Web of Science ®Google Scholar
• Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130(3):607–612.e609. doi:10.1016/j.jaci.2012.02.019
   PubMed Web of Science ®Google Scholar
• Akdis CA, Arkwright PD, Brüggen MC, et al. Type 2 immunity in the skin and lungs. Allergy. 2020;75(7):1582–1605. doi:10.1111/all.14318
   PubMed Web of Science ®Google Scholar
• Kiehl P, Falkenberg K, Vogelbruch M, Kapp A. Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol. 2001;145(5):720–729. doi:10.1046/j.1365-2133.2001.04456.x
   PubMed Web of Science ®Google Scholar
• Cetinkaya PG, Aytekin ES, Esenboga S, et al. Eosinophilia in children: characteristics, etiology and diagnostic algorithm. Eur J Pediatr. 2023;182(6):2833–2842. doi:10.1007/s00431-023-04961-x
   PubMedGoogle Scholar
• Crnković HT, Bendelja K, Šimić Klarić A, Tomić Rajić M, Drkulec V, Aberle N. Family history and cord blood eosinophil count as predictors for atopic manifestations. Cent Eur J Public Health. 2019;27(4):267–271. doi:10.21101/cejph.a5601
   PubMed Web of Science ®Google Scholar
• Hoetzenecker W, Nägeli M, Mehra ET, et al. Adverse cutaneous drug eruptions: current understanding. Semin Immunopathol. 2016;38(1):75–86. doi:10.1007/s00281-015-0540-2
   PubMed Web of Science ®Google Scholar
• Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017;390(10106):1996–2011. doi:10.1016/S0140-6736(16)30378-6
   PubMed Web of Science ®Google Scholar
• Yang J, Yang X, Li M. Peripheral blood eosinophil counts predict the prognosis of drug eruptions. J Investig Allergol Clin Immunol. 2013;23(4):248–255.
   PubMed Web of Science ®Google Scholar
• Kim TY, Park HJ, Kim CW. Eosinophil cationic protein (ECP) level and its correlation with eosinophil number or IgE level of peripheral blood in patients with various skin diseases. J Dermatol Sci. 1997;15(2):89–94. doi:10.1016/S0923-1811(97)00614-2
   PubMed Web of Science ®Google Scholar
• Sueki H, Nakada T, Iijima M. A case of psoriasis vulgaris with peripheral blood eosinophilia, parallelling the psoriasis area and severity index (PASI) score. Clin Exp Dermatol. 2004;29(5):549–550. doi:10.1111/j.1365-2230.2004.01566.x
   PubMed Web of Science ®Google Scholar
• Rothenberg ME. Eosinophilia. N Engl J Med. 1998;338(22):1592–1600. doi:10.1056/NEJM199805283382206
   PubMed Web of Science ®Google Scholar
• Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol. 2013;13(1):9–22. doi:10.1038/nri3341
   PubMed Web of Science ®Google Scholar
• Crotty C, Pittelkow M, Muller SA. Eosinophilic spongiosis: a clinicopathologic review of seventy-one cases. J Am Acad Dermatol. 1983;8(3):337–343. doi:10.1016/S0190-9622(83)70036-8
   PubMed Web of Science ®Google Scholar
• Morais KL, Miyamoto D, Maruta CW, Aoki V. Diagnostic approach of eosinophilic spongiosis. An Bras Dermatol. 2019;94(6):724–728. doi:10.1016/j.abd.2019.02.002
   PubMed Web of Science ®Google Scholar
• Garrido PM, Aguado-Lobo M, Espinosa-Lara P, Soares-Almeida L, Filipe P. Association of peripheral blood and cutaneous eosinophils with bullous pemphigoid disease severity and treatment outcomes. Actas Dermosifiliogr. 2022;113(9):881–887. doi:10.1016/j.ad.2022.05.021
   PubMed Web of Science ®Google Scholar
• Gore Karaali M, Koku Aksu AE, Cin M, Leblebici C, Kara Polat A, Gurel MS. Tissue eosinophil levels as a marker of disease severity in bullous pemphigoid. Australas J Dermatol. 2021;62(2):e236–e241. doi:10.1111/ajd.13547
   PubMed Web of Science ®Google Scholar
• Radonjic-Hoesli S, Martignoni Z, Cazzaniga S, et al. Characteristics of dermatological patients with blood eosinophilia: a retrospective analysis of 453 patients. J Allergy Clin Immunol Pract. 2022;10(5):1229–1237.e1228. doi:10.1016/j.jaip.2022.02.018
   PubMed Web of Science ®Google Scholar
• Salomon G, Severino M, Casassa E, et al. Skin manifestations of hypereosinophilic syndrome are polymorphous and difficult to treat: a retrospective cohort study. Ann Dermatol Venereol. 2022;149(2):139–141. doi:10.1016/j.annder.2021.12.002
   PubMed Web of Science ®Google Scholar
• Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009;124(6):1319–1325.e1313. doi:10.1016/j.jaci.2009.09.022
   PubMed Web of Science ®Google Scholar
• Neve S, Beukers S, Kirtschig G. Hypereosinophilic syndrome in an atopic patient. Clin Exp Dermatol. 2009;34(8):e643–646. doi:10.1111/j.1365-2230.2009.03356.x
   PubMed Web of Science ®Google Scholar
• Khallaayoune M, Sialiti S, Meziane M, Senouci K. Bullous pemphigoid-like rash revealing hypereosinophilic syndrome. BMJ Case Rep. 2021;14(6). doi:10.1136/bcr-2021-242695
   Google Scholar